TABLE 2.
Modification strategies for EV engineering.
Modification methods | Approaches | Results | References | |
---|---|---|---|---|
Indirect MSC modification strategies | Manipulating gene transfection | Virus transfection | Overexpressing miR-140–5p, and alleviating OA progress through downregulating VEGFA | Liu et al. (2022) |
Plasmid transfection | Upregulating circRNA_0001236, and inhibiting cartilage degradation via miR-3677–3p/Sox9 | Mao et al. (2021) | ||
Plasmid transfection | Overexpressing lncRNA H19, and promoting chondrogenesis through miR-29b-3p/FOXO3 | Yan et al. (2021) | ||
Co-incubating donor cells with bioactive molecules | Co-incubation with curcumin | Reducing the oxidative stress and protecting chondrocytes | Xu et al. (2022) | |
Co-incubation with TGF-β1 | Enhancing the M2 polarization via miR-135b/MAPK6 axis | Wang and Xu, (2021) | ||
Co-incubation with IL-1β | Inhibiting inflammation of OA | Kim et al. (2021) | ||
Co-incubation with LPS | Inhibiting cartilage matrix degradation | Duan et al. (2021) | ||
Engineering cell culture micro-environment | 3D culture | Promoting chondrogenesis | Yan and Wu, (2020) | |
Dynamic mechanical stimulation | Inhibiting inflammation via NF-κB signal pathway | Liao et al. (2021) | ||
Hypoxia micro-environment culture | Enhancing cartilage repair | Rong et al. (2021) | ||
Direct EV modification strategies | Enriching EV cargos | Direct mixture method | Loading COS into EVs, and promoting anabolic related genes expression of chondrocytes | Li et al. (2021a) |
Electroporation | Loading KGN into EVs, and improving cartilage repair | Xu et al. (2021) | ||
Modifying EV membrane | E7 peptide modifying EV surface | Targeting synovial fluid-derived MSCs | Xu et al. (2021) | |
Fusing CAP with EV surface protein | Improving the chondrocyte target ability | Liang et al. (2020) | ||
Modifying EVs with PPD | Regulating EV surface charge potential, and promoting EV penetration into cartilage matrix | Feng et al. (2021) |